Home LiteratureArticle Details
PMID: 7853478 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1.

Journal of virology ·Vol. 69 ·No. 3 ·1995-03-00 ·Pages 1462-72

Frey S, Marsh M, Günther S, Pelchen-Matthews A, Stephens P, Ortlepp S, Stegmann T

Abstract

We investigated cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1 strain IIIB expressed on the surface of CHO cells. These cells formed syncytia when incubated together with CD4-positive human lymphoblastoid SupT1 cells or HeLa-CD4 cells but not when incubated with CD4-negative cell lines. A new assay for binding and fusion was developed by using fluorescent phospholipid analogs that were produced in SupT1 cells by metabolic incorporation of BODIPY-labeled fatty acids. Fusion occurred as early as 10 min after mixing of labeled SupT1 cells with unlabeled CHO-gp160 cells at 37 degrees C. When both the fluorescence assay and formation of syncytia were used, fusion of SupT1 and HeLa-CD4 cells with CHO-gp160 cells was observed only at temperatures above 25 degrees C, confirming recent observations (Y.-K. Fu, T.K. Hart, Z.L. Jonak, and P.J. Bugelski, J. Virol. 67:3818-3825, 1993). This temperature dependence was not observed with influenza virus-induced cell-cell fusion, which was quantitatively similar at both 20 and 37 degrees C, indicating that cell-cell fusion in general is not temperature dependent in this range. gp120-CD4-specific cell-cell binding was found over the entire 0 to 37 degrees C range but increased markedly above 25 degrees C. The enhanced binding and fusion were reduced by cytochalasins B and D. Binding of soluble gp120 to CD4-expressing cells was equivalent at 37 and 16 degrees C. Together, these data indicate that during gp120-gp41-induced syncytium formation, initial cell-cell binding is followed by a cytoskeleton-dependent increase in the number of gp120-CD4 complexes, leading to an increase in the avidity of cell-cell binding. The increased number of gp120-CD4 complexes is required for fusion, which suggests that the formation of a fusion complex consisting of multiple CD4 and gp120-gp41 molecules is a step in the fusion mechanism.

MeSH Terms
Animals CD4 Antigens/metabolism CHO Cells Cell Fusion/drug effects Cricetinae Cytochalasin B/pharmacology Gene Products, env/physiology HIV Envelope Protein gp120/physiology HIV Envelope Protein gp160 HIV-1/pathogenicity In Vitro Techniques Protein Precursors/physiology Recombinant Proteins Temperature
Chemicals
CD4 Antigens Gene Products, env HIV Envelope Protein gp120 HIV Envelope Protein gp160 Protein Precursors Recombinant Proteins Cytochalasin B
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Frey S
Department of Biophysical Chemistry, Biozentrum of the University of Basel, Switzerland.
Marsh M
Günther S
Pelchen-Matthews A
Stephens P
Ortlepp S
Stegmann T
References (54)
54 references, click to expand
  1. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
    Science. 1987 Sep 11;237(4820):1351-5 PMID: 3629244
  2. Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures.
    J Virol. 1994 Aug;68(8):5264-9 PMID: 8035523
  3. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines.
    J Virol. 1988 Sep;62(9):3135-42 PMID: 2841466
  4. Effects of fusion temperature on the lateral mobility of Sendai virus glycoproteins in erythrocyte membranes and on cell fusion indicate that glycoprotein mobilization is required for cell fusion.
    Biochemistry. 1988 Jul 26;27(15):5654-61 PMID: 2846047
  5. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9580-4 PMID: 2849111
  6. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence.
    J Biol Chem. 1989 Mar 5;264(7):3972-8 PMID: 2917985
  7. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
    Nature. 1989 May 4;339(6219):68-70 PMID: 2541344
  8. Identification of the fusion peptide of primate immunodeficiency viruses.
    Science. 1989 May 12;244(4905):694-7 PMID: 2541505
  9. The adhension of Chinese hamster cells. I. Effects of temperature, metabolic inhibitors and proteolytic dissection of cell surface macromolecules.
    J Cell Physiol. 1977 Aug;92(2):209-20 PMID: 881433
  10. Effects of cytochalasin D on fusion of cells by HVJ (Sendai virus).
    Exp Cell Res. 1978 Oct 1;116(1):167-78 PMID: 212281
  11. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses.
    J Cell Biol. 1981 Jun;89(3):674-9 PMID: 6265470
  12. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  13. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8 PMID: 6083454
  14. Complete nucleotide sequence of the AIDS virus, HTLV-III.
    Nature. 1985 Jan 24-30;313(6000):277-84 PMID: 2578615
  15. Kinetics of pH-dependent fusion between influenza virus and liposomes.
    Biochemistry. 1985 Jun 18;24(13):3107-13 PMID: 4027233
  16. Characterization of the fusogenic properties of Sendai virus: kinetics of fusion with erythrocyte membranes.
    Biochemistry. 1985 Aug 27;24(18):4739-45 PMID: 3000417
  17. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    Science. 1986 Jan 24;231(4736):382-5 PMID: 3001934
  18. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  19. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
    Cell. 1986 Nov 7;47(3):333-48 PMID: 3094962
  20. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
    Nature. 1986 Oct 23-29;323(6090):725-8 PMID: 3095663
  21. Virus entry into animal cells.
    Adv Virus Res. 1989;36:107-51 PMID: 2500008
  22. Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: cytoplasmic continuity and lipid mixing.
    J Cell Biol. 1989 Jul;109(1):113-22 PMID: 2745545
  23. The construction of a highly efficient and versatile set of mammalian expression vectors.
    Nucleic Acids Res. 1989 Sep 12;17(17):7110 PMID: 2780323
  24. Lateral mobility of both envelope proteins (F and HN) of Sendai virus in the cell membrane is essential for cell-cell fusion.
    J Biol Chem. 1989 Oct 15;264(29):17119-25 PMID: 2551896
  25. Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response.
    J Cell Biol. 1989 Oct;109(4 Pt 1):1795-805 PMID: 2477381
  26. Gating kinetics of pH-activated membrane fusion of vesicular stomatitis virus with cells: stopped-flow measurements by dequenching of octadecylrhodamine fluorescence.
    Biochemistry. 1990 Feb 6;29(5):1303-8 PMID: 2157487
  27. The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines.
    J Virol. 1990 Jun;64(6):3100-3 PMID: 2186180
  28. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4 PMID: 2191297
  29. HIV requires multiple gp120 molecules for CD4-mediated infection.
    Nature. 1990 Jul 19;346(6281):277-9 PMID: 2374593
  30. Fusion of Rous sarcoma virus with host cells does not require exposure to low pH.
    J Virol. 1990 Oct;64(10):5106-13 PMID: 2168989
  31. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
    J Exp Med. 1990 Oct 1;172(4):1233-42 PMID: 1698911
  32. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Science. 1990 Nov 23;250(4984):1139-42 PMID: 2251501
  33. Intermediates in influenza induced membrane fusion.
    EMBO J. 1990 Dec;9(13):4231-41 PMID: 2265606
  34. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
    J Virol. 1991 Mar;65(3):1133-40 PMID: 1995942
  35. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93 PMID: 2006155
  36. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    J Exp Med. 1991 Aug 1;174(2):407-15 PMID: 1713252
  37. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1992 Jan;66(1):132-8 PMID: 1727475
  38. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
    J Virol. 1992 Jan;66(1):235-43 PMID: 1727487
  39. Fluorescent membrane probes incorporating dipyrrometheneboron difluoride fluorophores.
    Anal Biochem. 1991 Nov 1;198(2):228-37 PMID: 1799206
  40. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits.
    J Cell Biol. 1992 Apr;117(2):279-90 PMID: 1373141
  41. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    J Virol. 1992 Sep;66(9):5516-24 PMID: 1501286
  42. Membrane fusion.
    Science. 1992 Nov 6;258(5084):917-24 PMID: 1439803
  43. Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface: correlation between mobility inhibition and inactivation.
    Biochemistry. 1993 Jan 12;32(1):101-6 PMID: 8418830
  44. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion.
    J Virol. 1993 Mar;67(3):1365-72 PMID: 8437221
  45. Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein.
    EMBO J. 1993 Feb;12(2):693-701 PMID: 8440260
  46. How does HIV cause AIDS?
    Science. 1993 May 28;260(5112):1273-9 PMID: 8493571
  47. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.
    J Virol. 1993 Jul;67(7):3818-25 PMID: 8510207
  48. Cell adhesion mediated by CD4 and MHC class II proteins requires active cellular processes.
    J Immunol. 1993 Nov 1;151(9):4552-61 PMID: 8104997
  49. Evaluation of viral membrane fusion assays. Comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay.
    Biochemistry. 1993 Oct 26;32(42):11330-7 PMID: 8218197
  50. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1993 Dec;67(12):7060-6 PMID: 8230430
  51. Protein lateral mobility as a reflection of membrane microstructure.
    Bioessays. 1993 Sep;15(9):579-88 PMID: 8240310
  52. Virus receptors: binding, adhesion strengthening, and changes in viral structure.
    J Virol. 1994 Jan;68(1):1-5 PMID: 8254718
  53. Compartmentalized structure of the plasma membrane for receptor movements as revealed by a nanometer-level motion analysis.
    J Cell Biol. 1994 Jun;125(6):1251-64 PMID: 8207056
  54. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Nature. 1988 Jan 7;331(6151):84-6 PMID: 2829024
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1995-03-00
Pages
1462-72
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC188734
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com